Jamie Bignal

Director, Life Sciences & Healthcare, HSBC Innovation Banking

Jamie is a Director in HSBC Innovation Bank’s Life Science & Healthcare team. HSBC Innovation Banking provides commercial banking services, expertise and insights to the technology, life science and healthcare, private equity and venture capital industries. HSBC Innovation Banking UK is a subsidiary of HSBC Group, benefiting from its stability, strong credit rating and international reach to help fuel its growth

Olivia Cavlan

Chief Corporate Development and Strategy Officer, Alchemab

Olivia Cavlan is a founding team member and Chief Corporate Development and Strategy Officer at Alchemab Therapeutics. Prior to Alchemab Olivia was an Investment Principal at SV Health Investors and a Partner with McKinsey & Company where she was part of the leadership team in the Healthcare Private Equity and Pharmaceutical practices. Alongside her role as a Non-Executive Director for the UK BioIndustry Association, Olivia is a member of the Investment Committee for Cancer Research UK’s (CRUK) Seed fund. She also co-founded and sits on the Board of Directors of Sevenless Therapeutics, a small molecule pain company. Olivia is a medic originally, holding an MBChB in Medicine and a BSc in Pharmacology from Bristol University.

Dominick Peasley

CEO, SPRK Capital

Dominick is CEO of SPRK Capital. Prior to joining SPRK he was responsible for all lending capital at Funding Circle, the largest platform lender to small businesses in the UK. He joined pre-IPO to institutionalise their capital base and during his tenure there raised over £5bn of new capital to support SMEs in the UK. He was instrumental in the UK Government loan schemes, through CBILS, BBLS and most recently the RLS programme.

Before that, Dominick co-founded Capital-B a FinTech advisory and capital placement agency focused on developing lending businesses. Prior to this Dominick worked for Goldman Sachs where he headed distribution for its asset management business in the UK and with global banks. Dominick qualified as a chartered accountant with PwC and is a Fellow of the ICAEW. He holds a Masters in Engineering from Durham University.

Clare Terlouw

Head of LifeArc Ventures, LifeArc

Clare Terlouw is Head of LifeArc Ventures, responsible for LifeArc’s portfolio of direct and LP investments across the life sciences sector. The venture investment fund focuses on early stage life sciences companies at seed to Series A, with significant follow-on investment reserved for successful portfolio companies.

Clare has significant expertise in funding innovative life sciences companies in the private and public markets. She was previously Head of Corporate Development at Syncona Investment Management Ltd, a FTSE250 healthcare investment trust which builds and invests in life science companies, and has more than 15 years of biotech and healthcare financing experience as a UK investment banker at Nomura, Numis Securities and Peel Hunt. Clare was a physiotherapist in Canada prior to moving into finance.

Clare is a board member of the UK Biotechnology Industry Association and director of a number of venture-backed companies.

Hendrik Runge

CEO, Cambridge Nucleomics

Hendrik gained extensive sequencing experience from his PhD in haematological malignancies at the Cambridge Stem Cell Institute. He has raised funding for his previous social venture and worked with the healthcare accelerator Start Codon in Cambridge.